Cargando…
Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistance
Lithium has been shown to have some therapeutic efficacy as an adjunctive treatment for intractable forms of major depression. Activation of mammalian target of rapamycin (mTOR) and inhibition of glycogen synthase kinase-3β (GSK3β) have been implicated in its putative mechanisms of action. These pro...
Autores principales: | Walker, Adam J., Price, J. Blair, Borreggine, Kristin, Sutor, Shari L., Gogos, Andrea, McGillivray, Jane A., Frye, Mark A., Tye, Susannah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420640/ https://www.ncbi.nlm.nih.gov/pubmed/30877268 http://dx.doi.org/10.1038/s41398-019-0434-5 |
Ejemplares similares
-
Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression
por: Price, J. Blair, et al.
Publicado: (2021) -
Accelerated antidepressant response to lithium augmentation of imipramine
por: Saini, Rajiv, et al.
Publicado: (2016) -
Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention
por: Walker, Adam J., et al.
Publicado: (2014) -
Every reason to discontinue lithium
por: Salgado, Manuel E Fuentes, et al.
Publicado: (2014) -
Ghrelin Serum Concentrations Are Associated with Treatment Response During Lithium Augmentation of Antidepressants
por: Ricken, Roland, et al.
Publicado: (2017)